| |
| |
|
| Insider
Information: |
Oboyle Kevin C |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
267,712 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$543,963 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
267,712 |
|
|
| Total
Value |
$543,963 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 36.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nuvasive Inc |
NUVA |
CFO and Executive VP |
2009-12-15 |
3,338 |
|
0 |
Premium* |
|
|
Wright Medical Group N.V |
WMGI |
Director |
2020-11-11 |
0 |
2011-05-12 |
0 |
Premium* |
|
|
Genmark Diagnostics, Inc. |
GNMK |
Director |
2021-04-22 |
0 |
2012-06-06 |
0 |
Premium* |
|
|
Durata Therapeutics, Inc. |
DRTX |
Director |
2014-11-17 |
0 |
2012-07-19 |
0 |
Premium* |
|
|
Zeltiq Aesthetics Inc |
ZLTQ |
Director |
2017-04-28 |
0 |
2014-03-04 |
0 |
Premium* |
|
|
Sientra, Inc. |
SIEN |
Director |
2022-06-09 |
220,978 |
2016-06-23 |
0 |
Premium* |
|
|
Nevro Corp |
NVRO |
|
2024-05-23 |
43,396 |
2019-03-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SIEN |
Sientra, Inc. |
Director |
– • – |
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
103,306 |
220,978 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Director |
– • – |
2021-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,130 |
131,678 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Director |
– • – |
2019-08-15 |
4 |
OE |
$6.00 |
$258,300 |
D/D |
43,050 |
129,012 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Director |
– • – |
2020-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
17,998 |
121,548 |
0 |
- |
|
| SIEN |
Sientra, Inc. |
Director |
– • – |
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
16,870 |
117,672 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Director |
– • – |
2019-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
19,851 |
104,312 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Director |
– • – |
2020-03-06 |
4 |
B |
$4.53 |
$48,924 |
D/D |
10,800 |
103,550 |
2.39 |
% |
|
| GNMK |
Genmark Diagnostics, Inc. |
Director |
– • – |
2019-08-15 |
4 |
AS |
$6.51 |
$14,322 |
D/D |
(2,200) |
102,112 |
0 |
- |
|
| SIEN |
Sientra, Inc. |
Director |
– • – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
27,717 |
100,802 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Director |
– • – |
2020-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,973 |
92,750 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Director |
– • – |
2019-08-15 |
4 |
D |
$6.42 |
$258,309 |
D/D |
(40,235) |
88,777 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Director |
– • – |
2019-08-16 |
4 |
AS |
$6.51 |
$105,137 |
D/D |
(16,150) |
85,962 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Director |
– • – |
2018-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
18,866 |
84,461 |
0 |
- |
|
| SIEN |
Sientra, Inc. |
Director |
– • – |
2019-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
19,320 |
73,085 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Director |
– • – |
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
7,832 |
65,595 |
0 |
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Director |
– • – |
2016-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
9,965 |
57,763 |
0 |
- |
|
| NUVA |
Nuvasive Inc |
VP, Finance and CFO |
• – – |
2004-12-15 |
4 |
OE |
$3.75 |
$45,000 |
D/D |
12,000 |
55,333 |
|
- |
|
| SIEN |
Sientra, Inc. |
Director |
– • – |
2019-06-07 |
4 |
B |
$5.75 |
$50,002 |
D/D |
8,696 |
53,765 |
2.39 |
- |
|
| WMGI |
Wright Medical Group N.V |
Director |
– • – |
2019-01-31 |
4 |
OE |
$22.50 |
$693,360 |
D/D |
30,816 |
53,206 |
0 |
- |
|
| NUVA |
Nuvasive Inc |
CFO and Executive VP |
• – – |
2005-02-14 |
4 |
OE |
$3.75 |
$18,750 |
D/D |
5,000 |
48,333 |
|
- |
|
| NUVA |
Nuvasive Inc |
CFO and Executive VP |
• – – |
2005-03-14 |
4 |
OE |
$3.75 |
$18,750 |
D/D |
5,000 |
48,333 |
|
- |
|
| NUVA |
Nuvasive Inc |
CFO and Executive VP |
• – – |
2005-04-14 |
4 |
OE |
$3.75 |
$18,750 |
D/D |
5,000 |
48,333 |
|
- |
|
| NUVA |
Nuvasive Inc |
CFO and Executive VP |
• – – |
2005-06-14 |
4 |
OE |
$3.75 |
$18,750 |
D/D |
5,000 |
48,333 |
|
- |
|
| GNMK |
Genmark Diagnostics, Inc. |
Director |
– • – |
2015-11-03 |
4 |
B |
$6.71 |
$30,195 |
D/D |
4,500 |
47,798 |
2.39 |
- |
|
| NUVA |
Nuvasive Inc |
CFO and Executive VP |
• – – |
2006-11-14 |
4 |
OE |
$0.63 |
$4,725 |
D/D |
7,500 |
47,764 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
